8 Also in Japan, in 2007, patients with the incurable neurodegenerative disease ALS (Lou Gehrigs disease) received daily injections with 25 mg methylcobalamin for 4 weeks, followed by daily injections of 50 mg intravenously, followed by 50 mg a week
Too little can lead to deficiency, while excessive amounts may cause unwanted side effects
As of 2025, AOD-9604 should be regarded as a discontinued research peptide, not a therapeutic agent , with ongoing relevance confined to academic and mechanistic exploration
Boosts metabolism and immune system Flushes out toxins through deep sweating Powerful antioxidant support for cellular health
it's a nuanced decision driven by your specific research objectives, experimental design, and logistical capabilities
Quality assurance of peptide preparations represents a significant concern requiring careful evaluation of suppliers and manufacturing standards